Posts Tagged: Molly Shoichet
University Professor Molly Shoichet has been elected a Fellow of the National Academy of Inventors (NAI).
A U of T Engineering research team has created a new platform that delivers multiple therapeutic proteins to the body, each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50.
A team of U of T Engineering researchers, led by Professor Molly Shoichet (ChemE, BME, Donnelly), has designed a new way to grow cells in a laboratory that enables them to better emulate cancerous tumours.
Having exposure to biomedical sciences at a young age, Amber Xue continued her passion for clinical research at Molly Shoichet’s lab. She is also actively engaged in knowledge translation from academia to industry.
May 6, 2022 | A diverse group of 14 outstanding achievers will receive the university’s highest honour this June.
February 23, 2022 | Two BME students receives Dorrington Graduate Award.
January 17, 2022 | University of Toronto (U of T) professors Shana Kelley, Leslie Dan Faculty of Pharmacy, and Molly Shoichet, Institute of Biomedical Engineering, will be supported by Medicine by Design’s Pivotal Experiment Fund to spin-off aspects of their research into an early-stage product concept or venture.
January 12, 2022 | Spinal cord injuries can be devastating to those who experience them. Currently, almost no options are available to reverse the effects, which can include paralysis, chronic pain and loss of bladder control. But an international team of researchers — including University Professor Molly Shoichet (ChemE, BME, Donnelly) — hopes to change that.
October 25, 2021 | To study the biological properties of DMD, a degenerative muscle disorder that mainly affects males, U of T researchers obtained cell lines from people living with the condition and used them to create miniature muscles in a dish.
January 6, 2021 | Supported by U of T's Medicine by Design initiative, a multidisciplinary team led by University Professor Molly Shoichet (ChemE, BME, Donnely) plans to use retinal stem cells to restore vision.
Showing 1 - 10 of 38 results